The value of measuring anti-Müllerian hormone in women with anovulatory polycystic ovary syndrome undergoing laparoscopic ovarian diathermy

Human Reproduction

Volumn 24, Issue 11, 2009, Pages 2760-2766

  Amer, S A ^a   Li, T C ^b   Ledger, W L ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Anti M llerian hormone; Clomiphene citrate; Laparoscopic ovarian diathermy; Ovulation; Polycystic ovary syndrome

Indexed keywords

CLOMIFENE CITRATE; HORMONE ANTIBODY; MULLERIAN HORMONE ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DIATHERMY; FEMALE; HUMAN; LAPAROSCOPIC SURGERY; OVARY POLYCYSTIC DISEASE; OVULATION; POSTOPERATIVE PERIOD; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

EID: 70350514771     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/dep271     Document Type: Article

References (21)

1. Amer S, Li TC, Banu Z, Cooke ID.Long term follow up of patients with polycystic ovarian syndrome after laparoscopic ovarian drilling: endocrine and ultrasonographic outcomes. Hum Reprod 2002; 17:2851-2857. (Pubitemid 35350901)
2. Amer S, Li TC, Ledger WL. Ovulation induction using laparoscopic ovarian drilling in women with polycystic ovarian syndrome: predictors of success. Hum Reprod 2004;19:1719-1724.
3. Amer S, Li TC, Emarh M, Metwally M, Ledger WL. Randomized controlled trial comparing laparoscopic ovarian diathermy with clomiphene citrate as a first line method of ovulation induction in women with polycystic ovarian syndrome. Hum Reprod 2009;24:219-225.
4. Armar NA, McGarrigle HHG, Honour J, Holownia P, Jacobs HS, Lachelin GC. Laparoscopic ovarian diathermy in the management of anovulatory infertility in women with polycystic ovaries: endocrine changes and clinical outcome. Fertil Steril 1990;53:45-49.
5. Cook CL, Siow Y, Taylor S, Fallat ME. Serum Müllerian-inhibiting substance levels during normal menstrual cycles. Fertil Steril 2000;73:859-861.
6. Di Clemente N, Goxe B, Rémy JJ, Cate RL, Josso N, Vigier B, Salesse R. Inhibitory effect of AMH upon aromatase activity and LH receptors of granulosa cells of rat and porcine immature ovaries. Endocrine 1994; 2:553-558.
7. Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology 1999;140:5789-5796.
8. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA et al. Anti-Müllerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 2001;142:4891-4899.
9. Eldar-Geva T, Margalioth EJ, Gal M, Ben-Chetrit A, Algur N, Zylber-Haran E, Brooks B, Huerta M, Spitz IM. Serum anti-Mullerian hormone levels during controlled ovarian hyperstimulation in women with polycystic ovaries with and without hyperandrogenism. Hum Reprod 2005;20:1814-1819.
10. El-Halawaty S, Rizk A, Kamal M, Aboulhassan M, Al-Sawah H, Noah O, Al-Inany H. Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome. Reprod Biomed Online 2007;15:495-499.
11. Fanchin R, Schonauer LM, Righini C, Frydman N, Frydman R, Taieb J. Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod 2003;18:328-332.
12. Kwee J, Schats R, McDonnell J, Themmen A, de Jong F, Lambalk C. Evaluation of anti-Müllerian hormone as a test for the prediction of ovarian reserve. Fertil Steril 2008;90:737-743.
13. Laven JS, Mulders AG, Visser JA, Themmen APN, De Jong FH, Fauser BC. Anti-Mullerian hormone serum concentrations in normoovulatory and anovulatory women of reproductive age. J Clin Endocrinol Metab 2004; 89:318-323.
14. Li TC, Spuijbroek MD, Tuckerman E, Anstie B, Loxley M, Laird S. Endocrinological and endometrial factors in recurrent miscarriage. Br J Obstet Gynaecol 2000;107:1471-1479.
15. Nardo LG, Gelbaya TA, Wilkinson H, Roberts SA, Yates A, Pemberton P, Laing I. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization. Fertil Steril 2008; doi:10.016/j.fertnstert.2008.8.127.
16. Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S, Dewailly D. Elevated serum level of anti-Mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 2003; 88:5957-5962.
17. Seifer DB, MacLaughlin DT, Christian BP, Feng B, Shelden RMF. Early follicular serum Mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 2002;77:468-471.
18. Van Rooij IA, Broekmans FJ, Te Velde ER, Fauser BC, Bancsi LF, Jong FH, Themmen AP. Serum AMH levels: a novel measure of ovarian reserve. Hum Reprod 2002;17:3065-3071.
19. Vendola K, Zhou J, Adesanay O, Wiel S, Bondy C. Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998;101:2622-2629.
20. Visser JA, de Jong FH, Laven JSE, Themmen APN. Anti-Müllerian hormone: a new marker for ovarian function. Reproduction 2006; 131:1-9.
21. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP. Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004; 10:77-83.